Categories: EHRNews

Jushi Holdings Inc. to Report Second Quarter 2023 Financial Results on August 11, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BOCA RATON, Fla., July 28, 2023 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the second quarter ended June 30, 2023, before the market opens on Friday, August 11, 2023.

Management will host a conference call and audio webcast on Friday, August 11, 2023, at 8:00 a.m. ET to discuss the Company’s financial results.

Event: Second Quarter 2023 Financial Results Conference Call
Date: Friday, August 11, 2023
Time: 8:00 a.m. Eastern Time
Live Call: 1-877-407-0792 (U.S. & Canada Toll-Free)
Conference ID 13739697
Webcast: Register
   

For interested individuals unable to join the conference call, a webcast of the call will be available until September 11, 2023 and can be accessed via webcast on Jushi’s Investor Relations website.

About Jushi Holdings Inc.

We are a vertically integrated cannabis company led by an industry-leading management team. Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or our social media channels, InstagramFacebookTwitter, and LinkedIn.

For further information, please contact:

Investor Relations
Lisa Forman
Director of Investor Relations
617-767-4419
investors@jushico.com

Media Contact
Ellen Mellody
MATTIO Communications
570-209-2947
jushi@mattio.com

Staff

Recent Posts

LevelJump to Acquire Two Alberta Diagnostic Imaging Clinics; Update on Year-End Reporting Documents

Toronto, Ontario--(Newsfile Corp. - June 13, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or…

54 minutes ago

Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2…

54 minutes ago

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard®…

54 minutes ago

Izotropic Provides Marketing Update

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - June 13, 2025) - Izotropic Corporation (CSE:…

2 hours ago

Glassbeam Awarded FedRAMP Authorization for its SAAS analytics solution for connected medical systems by the U.S. Department of Veterans Affairs.

This designation enables Glassbeam to support federal government agency customers increase uptime for all MRI…

4 hours ago

XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration

CAMBRIDGE, Mass. and LIVERPOOL, United Kingdom, June 13, 2025 /PRNewswire/ -- XtalPi, a leading life…

4 hours ago